PharmaSeq, Inc.

PharmaSeq, Inc. has developed the only light-activated microtransponder, also known as a “p-Chip”, that is used in a variety of life science and RFID applications. A microtransponder is a 500-micron-size silicon chip that, when illuminated by light, emits a radio frequency signal carrying its ID number. This number uniquely identifies the chip and the product to which it is attached; or alternatively, permits the identification of the biomolecules attached to the chip. PharmaSeq's versatile platform has led to two major applications:

RFID

The microtransponder has multiple uses in tagging and authentication applications where small size is essential. When used in conjunction with a proprietary injector, p-Chips can be placed under the skin of small animals, such as laboratory mice, and used to track them through experiments in research and pre-clinical trials.

Bioassays

When used in conjunction with biological probes, nucleic acids or proteins, and a high-throughput analyzer, microtransponders can facilitate the detection of multiple substances in a single biological sample. This is known as a “multiplex” assay and has been demonstrated in a diagnostic test that detects fifty different mutations related to cystic fibrosis, a major genetic disease.

PharmaSeq has a number of patents and patents pending related to microtransponder technology. PharmaSeq is privately held and based near Princeton, NJ.

See Us

Meet a PharmaSeq representative at the following conferences:

American Association for Laboratory Animal Science (AALAS) Tri-Branch Symposium, June 11-13, 2012, Atlantic City Convention Center, Atlantic City, New Jersey.

Press Releases

NIH funds Tagging of Histopathology Specimens at PharmaSeq (2/1/11)
PharmaSeq Receives Phase II SBIR Grant for Small Animal Tagging (9/20/10)
PharmaSeq Receives Government Grant to Develop Nanotechnology-based Protein Multiplex Assay for Prostate Cancer (8/20/10)
PharmaSeq to Deliver Talk at International RFID Conference (8/2/10)
read more...